Early-Phase Clinical Trials in Colombia

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Early-Phase Clinical Trials in Colombia

Early-Phase Clinical Trials in Colombia – Clinical Research in South America

In the fast-paced realm of medical research, early-phase clinical trials are the vanguard of innovation, propelling the discovery of groundbreaking treatments and therapies. Colombia, a nation with a rich cultural tapestry and a burgeoning healthcare landscape, has emerged as a pivotal destination for conducting these pivotal trials.

This blog takes a deep dive into the landscape of early-phase clinical trials in Colombia, uncovering the reasons behind its growing appeal, the regulatory framework, benefits, challenges, and the broader implications for global medical progress.

Colombia’s Appeal for Early-Phase Clinical Trials

Colombia’s burgeoning allure for early-phase clinical trials stems from a convergence of factors that make it an attractive venue for these vital studies. Its diverse population, encompassing various ethnicities and genetic backgrounds, presents a unique opportunity for researchers to assess treatment efficacy across a broad spectrum of genetic profiles. This diversity enhances the applicability of trial findings to global patient populations.

Moreover, the cost-effectiveness of conducting clinical trials in Colombia significantly contributes to its appeal. The relatively lower expenses associated with trials, including patient recruitment, site maintenance, and operational costs, make Colombia a fiscally viable choice for research endeavors. Importantly, this financial viability does not compromise the integrity of research or the ethical standards upheld during these trials.

Regulatory Framework and Ethical Considerations

Colombia boasts a robust regulatory framework for clinical trials, ensuring the safety of patients, integrity of data, and adherence to ethical principles. The National Institute for Food and Drug Surveillance (INVIMA) serves as the governing body responsible for overseeing clinical trials and ensuring compliance with both national and international standards. Ethical considerations take center stage, with clinical trial protocols undergoing rigorous evaluation by ethics committees before initiation.

Benefits and Contributions

The advantages of conducting early-phase clinical trials in Colombia extend beyond financial incentives. By participating in these trials, Colombian patients gain access to cutting-edge treatments that may otherwise remain beyond their reach. This cultivates a sense of community engagement and contributes to the dissemination of medical knowledge among healthcare professionals.

Furthermore, collaboration between international research entities and local institutions bolsters Colombia’s healthcare infrastructure. This partnership facilitates the exchange of knowledge, supports the development of local researchers, and strengthens the capacity for advanced clinical research. The presence of these trials fosters the growth of specialized clinical research centers, attracting expertise and investments to the nation’s healthcare sector.

Early-Phase Clinical Trials in Colombia

Early-Phase Clinical Trials in Colombia

Early-Phase Clinical Trials in Colombia

Challenges and Mitigation

While Colombia presents a promising environment for early-phase clinical trials, challenges do arise. A significant challenge lies in maintaining a consistent supply of qualified investigators and site personnel capable of conducting trials according to international standards. Addressing this challenge requires investments in education and training programs to elevate the skills of healthcare professionals engaged in clinical research.

Another challenge centers on patient recruitment and retention. Enrolling a sufficient number of participants within specific criteria can prove to be a hurdle. Transparent patient communication and engagement strategies, coupled with culturally sensitive approaches, are essential for overcoming these recruitment challenges.

Global Implications

Colombia’s role in early-phase clinical trials carries implications that resonate globally. The insights gleaned from trials conducted within the country have far-reaching effects, particularly for diseases prevalent in diverse populations. These trials contribute to the advancement of personalized medicine, where treatments are tailored to individual genetic profiles, enhancing efficacy and reducing adverse effects.

Additionally, Colombia’s involvement in early-phase clinical trials accelerates medical innovation on a global scale. As new treatments emerge, they become integrated into global healthcare practices, benefitting patients across the world. Colombia’s collaborative approach to clinical research establishes a precedent for international partnerships and knowledge-sharing that transcends geographical boundaries.


Early-phase clinical trials in Colombia encapsulate the fusion of medical progress, patient care, and international collaboration. The country’s diverse population, robust regulatory environment, and cost-effectiveness position it at the forefront of this pivotal facet of medical research. As Colombia continues to shape the trajectory of healthcare innovation, the world watches with anticipation, recognizing its role in advancing global health and the frontiers of medical science.

Early-Phase Clinical Trials in Colombia

Source: Pro Colombia

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Early-Phase Clinical Trials in Colombia

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Early-Phase Clinical Trials in Colombia

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Early-Phase Clinical Trials in Colombia

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Early-Phase Clinical Trials in Colombia

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Early-Phase Clinical Trials in Colombia

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Early-Phase Clinical Trials in Colombia

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Early-Phase Clinical Trials in Colombia

The Cohortias Team

Early-Phase Clinical Trials in Colombia

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Early-Phase Clinical Trials in Colombia

Network & Partnerships